pcDNA3.1/V5-His-TOPO-mir17-92 Citations (5)
Originally described in: c-Myc-regulated microRNAs modulate E2F1 expression.O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT Nature. 2005 Jun 9. 435(7043):839-43. PubMed Journal
Articles Citing pcDNA3.1/V5-His-TOPO-mir17-92
Articles |
---|
Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sultmann H, Scheffner M, Hoppe-Seyler K, Hoppe-Seyler F. PLoS Pathog. 2015 Mar 11;11(3):e1004712. doi: 10.1371/journal.ppat.1004712. eCollection 2015 Mar. PubMed |
Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA. Velagapudi SP, Luo Y, Tran T, Haniff HS, Nakai Y, Fallahi M, Martinez GJ, Childs-Disney JL, Disney MD. ACS Cent Sci. 2017 Mar 22;3(3):205-216. doi: 10.1021/acscentsci.7b00009. Epub 2017 Mar 6. PubMed |
p53-mediated miR-18 repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy in hypertension-induced heart failure. Huang CY, Pai PY, Kuo CH, Ho TJ, Lin JY, Lin DY, Tsai FJ, Padma VV, Kuo WW, Huang CY. Cell Death Dis. 2017 Aug 10;8(8):e2990. doi: 10.1038/cddis.2017.320. PubMed |
Genome-wide miRNA profiling and pivotal roles of miRs 125a-5p and 17-92 cluster in human neutrophil maturation and differentiation of acute myeloid leukemia cells. Dakir EH, Mollinedo F. Oncotarget. 2019 Sep 3;10(51):5313-5331. doi: 10.18632/oncotarget.27123. eCollection 2019 Sep 3. PubMed |
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature. Martens-de Kemp SR, Komor MA, Hegi R, Bolijn AS, Tijssen M, de Groen FLM, Depla A, van Leerdam M, Meijer GA, Fijneman RJA, Carvalho B. Neoplasia. 2022 Oct;32:100820. doi: 10.1016/j.neo.2022.100820. Epub 2022 Jul 21. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.